Firmenich, Finlays partner to bring tea, coffee solutions in Europe
Chr. Hansen ranks No. 2 on Canadian Corporate Knights’ 2022 Global 100 sustainability list
Geneva, Switzerland-based Firmenich and Finlays, part of the Swire Group, announced they have joined forces in Europe to help brands capitalize on growth in natural, sustainably sourced tea and coffee solutions. As a part of this new agreement, Firmenich will focus on commercializing two core parts of Finlays’ extracts business in Europe: its Cold Brew Coffee and Tea Extract portfolios. The Cold Brew Coffee portfolio serves a rapidly growing segment within the European region, and is crafted using a proprietary process that delivers a distinctly smooth, rich flavor experience, it says. Finlays’ Tea Extract portfolio includes The Wellbeing Collection, a range of premium, all-natural tea extracts that are rich in bioactive compounds associated with various health benefits, it adds. Under the new agreement, Firmenich is responsible for the full sales process, including commercial relationship and brief management, supported by the Finlays team. “The world of natural beverages is a dynamic hotbed of innovation and offers countless opportunities for sustainable growth,” said Guy Chambers, Finlays group managing director, in a statement. “Our new partnership with Firmenich supports Finlays’ mission of bringing the best from bush to cup and will help us to deliver distinctive and exciting solutions for customers in Europe.”
In response to rising demand for premium collagen ingredients, Rousselot Darling Ingredients, Irving, Texas, is increasing its production capabilities for premium porcine collagen, which is taking a more prominent role in the nutraceutical market. A newly opened production line in Ghent, Belgium, is specializing in the manufacture of Peptan, the leading collagen peptide brand, the company says. The new line complements Rousselot’s existing bovine and fish collagen production capabilities and will improve the manufacturers’ access to premium collagen ingredients and speed to market capabilities. Starting with two collagen peptide production facilities in 2019, the company now has four sites in Angoulême (France), Amparo and Presidente Epitácio (Brazil), and now, the dedicated premium porcine collagen in Ghent. The Ghent site also houses the company’s Global Expertise Center, where science and innovation teams harness research and development (R&D) and application labs, a sensory program and a pilot hall to drive the organization’s innovation pipeline.